Tyrosine kinase inhibitors targeting vascular endothelial growth factor and the risk of aortic dissection—A pharmacovigilance analysis

There are concerns by the United States Food and Drug Administration (FDA) regarding a potential link between tyrosine kinase inhibitors targeting vascular endothelial growth factor (VEGF‐TKIs) and the risk of aortic dissection. Elevation of blood pressure induced by VEGF‐TKIs has been discussed as...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pharmacol Res Perspect
Autors principals: Dörks, Michael, Jobski, Kathrin, Herget‐Rosenthal, Stefan, Hoffmann, Falk, Douros, Antonios
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2021
Matèries:
Short Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7796803/
https://ncbi.nlm.nih.gov/pubmed/33421342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.707
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars